Clinical and prognostic value of tumor volumetric parameters in melanoma patients undergoing


Journal

Cancer imaging : the official publication of the International Cancer Imaging Society
ISSN: 1470-7330
Titre abrégé: Cancer Imaging
Pays: England
ID NLM: 101172931

Informations de publication

Date de publication:
06 Jul 2020
Historique:
received: 16 04 2020
accepted: 29 06 2020
entrez: 8 7 2020
pubmed: 8 7 2020
medline: 3 11 2020
Statut: epublish

Résumé

To investigate the association of tumor volumetric parameters in melanoma patients undergoing A patient cohort with advanced melanoma undergoing One hundred seven patients (52 female; 65 ± 13.1yr.) were included. LDH was strongly associated with MTV (r Tumor volumetric parameters in

Sections du résumé

BACKGROUND BACKGROUND
To investigate the association of tumor volumetric parameters in melanoma patients undergoing
METHODS METHODS
A patient cohort with advanced melanoma undergoing
RESULTS RESULTS
One hundred seven patients (52 female; 65 ± 13.1yr.) were included. LDH was strongly associated with MTV (r
CONCLUSIONS CONCLUSIONS
Tumor volumetric parameters in

Identifiants

pubmed: 32631431
doi: 10.1186/s40644-020-00322-1
pii: 10.1186/s40644-020-00322-1
pmc: PMC7339397
doi:

Substances chimiques

Biomarkers, Tumor 0
Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Comparative Study Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

44

Subventions

Organisme : Medizinischen Fakultät, Eberhard Karls Universität Tübingen
ID : Junior Clinician Scientist Program

Références

Am J Nucl Med Mol Imaging. 2016 Apr 24;6(2):120-7
pubmed: 27186439
J Nucl Med. 2012 Jan;53(1):4-11
pubmed: 22213818
Eur J Surg Oncol. 2011 Mar;37(3):225-32
pubmed: 21277729
J Clin Oncol. 2001 Feb 1;19(3):824-31
pubmed: 11157036
Clin Cancer Res. 2011 Apr 15;17(8):2417-25
pubmed: 21487066
Lancet Oncol. 2015 Aug;16(8):908-18
pubmed: 26115796
Br J Cancer. 2004 Aug 16;91(4):699-702
pubmed: 15280926
Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):1969-1983
pubmed: 28689281
J Cell Mol Med. 2016 May;20(5):825-35
pubmed: 26928771
J Nucl Med. 2014 Jun;55(6):884-90
pubmed: 24752671
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Clin Positron Imaging. 1999 May;2(3):159-171
pubmed: 14516540
J Dermatol. 2011 Sep;38(9):880-6
pubmed: 21658116
Eur J Nucl Med Mol Imaging. 2015 Feb;42(2):328-54
pubmed: 25452219
Eur J Cancer. 2012 Mar;48(5):695-702
pubmed: 21917447
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):930-939
pubmed: 30488098
J Nucl Med. 2012 Jul;53(7):1041-7
pubmed: 22627001
Amino Acids. 2011 Oct;41(4):843-7
pubmed: 20204434
J Clin Oncol. 2006 Mar 1;24(7):1178-87
pubmed: 16505438
Mediators Inflamm. 2017;2017:9074601
pubmed: 28316376
J Dtsch Dermatol Ges. 2013 Aug;11 Suppl 6:1-116, 1-126
pubmed: 24028775
Oncology (Williston Park). 2018 May 15;32(5):228-34
pubmed: 29847853
Br J Cancer. 2018 Aug;119(3):339-346
pubmed: 29950611
Clin Biochem. 2004 Jul;37(7):512-8
pubmed: 15234232
J Nucl Med. 2006 Nov;47(11):1808-12
pubmed: 17079814
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1312-1318
pubmed: 28315947
N Engl J Med. 1999 Feb 11;340(6):448-54
pubmed: 9971870
BMC Cancer. 2011 Aug 02;11:328
pubmed: 21810220
Amino Acids. 2011 Oct;41(4):809-20
pubmed: 21153848
Melanoma Res. 1996 Apr;6(2):133-7
pubmed: 8791271
N Engl J Med. 2015 Jan 22;372(4):320-30
pubmed: 25399552
J Clin Oncol. 2016 Oct 20;34(30):3591-3594
pubmed: 27601547
J Nucl Med. 2009 May;50 Suppl 1:122S-50S
pubmed: 19403881
Br J Cancer. 2012 Jul 24;107(3):422-8
pubmed: 22782342
Melanoma Res. 1992 Sep;2(3):181-9
pubmed: 1450672
EJNMMI Res. 2016 Dec;6(1):21
pubmed: 26944734
Front Oncol. 2019 Oct 09;9:995
pubmed: 31649874
Tumour Biol. 2002 Jan-Feb;23(1):39-44
pubmed: 11893905
JAMA. 2016 Apr 19;315(15):1600-9
pubmed: 27092830
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):54-64
pubmed: 30269155
J Nucl Med. 2014 Jun;55(6):898-904
pubmed: 24711649
Clin Nucl Med. 2016 Jun;41(6):e266-73
pubmed: 27055144
N Engl J Med. 2017 Oct 5;377(14):1345-1356
pubmed: 28889792
Carcinogenesis. 2017 Feb 1;38(2):119-133
pubmed: 27993896
Blood. 1989 Jul;74(1):1-10
pubmed: 2473791
Eur J Nucl Med Mol Imaging. 2012 Oct;39(10):1592-8
pubmed: 22801730
Hematol Oncol Clin North Am. 2009 Jun;23(3):501-13, ix
pubmed: 19464599
J Clin Oncol. 2015 Apr 20;33(12):1389-96
pubmed: 25779565
J Clin Oncol. 2009 Dec 20;27(36):6199-206
pubmed: 19917835
Br J Cancer. 2017 Apr 25;116(9):1141-1147
pubmed: 28324889
Lancet Oncol. 2018 Nov;19(11):1480-1492
pubmed: 30361170
EJNMMI Res. 2018 Nov 20;8(1):101
pubmed: 30460579
EJNMMI Phys. 2014 Dec;1(1):99
pubmed: 26501457
Int J Cancer. 2008 Nov 15;123(10):2370-6
pubmed: 18752249

Auteurs

Christian Philipp Reinert (CP)

Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, Hoppe-Seyler-Str.3, 72076, Tübingen, Germany. christian.reinert@med.uni-tuebingen.de.

Sergios Gatidis (S)

Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, Hoppe-Seyler-Str.3, 72076, Tübingen, Germany.

Julia Sekler (J)

Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, Hoppe-Seyler-Str.3, 72076, Tübingen, Germany.

Helmut Dittmann (H)

Department of Radiology, Nuclear Medicine and Clinical Molecular Imaging, University Hospital, Tübingen, Hoppe-Seyler-Str.3, 72076, Tübingen, Germany.

Christina Pfannenberg (C)

Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, Hoppe-Seyler-Str.3, 72076, Tübingen, Germany.

Christian la Fougère (C)

Department of Radiology, Nuclear Medicine and Clinical Molecular Imaging, University Hospital, Tübingen, Hoppe-Seyler-Str.3, 72076, Tübingen, Germany.
Cluster of Excellence iFIT (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
German Cancer Consortium (DKTK). Partner Site Tübingen, Tübingen, Germany.

Konstantin Nikolaou (K)

Department of Radiology, Diagnostic and Interventional Radiology, University Hospital Tübingen, Hoppe-Seyler-Str.3, 72076, Tübingen, Germany.
Cluster of Excellence iFIT (EXC 2180) "Image Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
German Cancer Consortium (DKTK). Partner Site Tübingen, Tübingen, Germany.

Andrea Forschner (A)

Department of Dermatology, University Hospital Tübingen, Liebermeisterstrasse 25, 72076, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH